Thromboembolic events associated with bevacizumab plus chemotherapy for patients with colorectal cancer: a meta-analysis of randomized controlled trials AK Alahmari, ZS Almalki, AK Alahmari, JJ Guo American Health & Drug Benefits 9 (4), 221, 2016 | 56 | 2016 |
Cardiovascular events and safety outcomes associated with azithromycin therapy: a meta-analysis of randomized controlled trials ZS Almalki, JJ Guo American health & drug benefits 7 (6), 318, 2014 | 41 | 2014 |
Economic burden and treatment patterns of gynecologic cancers in the United States: evidence from the Medical Expenditure Panel Survey 2007–2014 X Yue, JM Pruemer, AL Hincapie, ZS Almalki, JJ Guo Journal of gynecologic oncology 31 (4), 2020 | 39 | 2020 |
Evaluation of medication error rates in Saudi Arabia: A protocol for systematic review and meta-analysis ZS Almalki, N Alqahtani, NT Salway, MM Alharbi, A Alqahtani, N Alotaibi, ... Medicine 100 (9), e24956, 2021 | 36 | 2021 |
Assessing the severity of illness in patients with coronavirus disease in Saudi Arabia: a retrospective descriptive cross-sectional study AM Alqahtani, ZS AlMalki, RM Alalweet, SH Almazrou, AS Alanazi, ... Frontiers in public health 8, 593256, 2020 | 36 | 2020 |
Utilization, spending, and price trends for quinolones in the US Medicaid programs: 25 years’ experience 1991–2015 ZS Almalki, X Yue, Y Xia, PR Wigle, JJ Guo PharmacoEconomics-Open 1, 123-131, 2017 | 34 | 2017 |
The economic burden of overweight and obesity in Saudi Arabia JD Malkin, D Baid, RF Alsukait, T Alghaith, M Alluhidan, H Alabdulkarim, ... PLoS One 17 (3), e0264993, 2022 | 33 | 2022 |
Development and characterization of gentamicin-loaded arabinoxylan-sodium alginate films as antibacterial wound dressing AI Alzarea, NK Alruwaili, MM Ahmad, MU Munir, AM Butt, ZA Alrowaili, ... International Journal of Molecular Sciences 23 (5), 2899, 2022 | 31 | 2022 |
Surveillance of post-vaccination side effects of COVID-19 vaccines among Saudi population: a real-world estimation of safety profile AI Alzarea, YH Khan, AD Alatawi, AS Alanazi, SI Alzarea, MH Butt, ... Vaccines 10 (6), 924, 2022 | 29 | 2022 |
Prevalence, risk factors, and management of uncontrolled hypertension among patients with diabetes: A hospital-based cross-sectional study ZS Almalki, AA Albassam, NS Alhejji, BS Alotaibi, LA Al-Oqayli, NJ Ahmed Primary care diabetes 14 (6), 610-615, 2020 | 25 | 2020 |
Assessing quality of life using WHOQOL-BREF: A cross-sectional insight among patients on warfarin in Malaysia MS Iqbal, YW Kassab, FI Al-Saikhan, ZS Almalki, A Haseeb, MZ Iqbal, ... Saudi Pharmaceutical Journal 28 (8), 936-942, 2020 | 25 | 2020 |
AMPK/mTOR-driven autophagy & Nrf2/HO-1 cascade modulation by amentoflavone ameliorates indomethacin-induced gastric ulcer MF Balaha, ZS Almalki, AK Alahmari, NJ Ahmed, MF Balaha Biomedicine & Pharmacotherapy 151, 113200, 2022 | 23 | 2022 |
Clinical characteristics and outcomes among COVID-19 hospitalized patients with chronic conditions: A retrospective single-center study ZS Almalki, MF Khan, S Almazrou, AS Alanazi, MS Iqbal, A Alqahtani, ... Journal of Multidisciplinary Healthcare, 1089-1097, 2020 | 23 | 2020 |
Patient-centered medical home care access among adults with chronic conditions: National Estimates from the medical expenditure panel survey ZS Almalki, NA Karami, IA Almsoudi, RK Alhasoun, AT Mahdi, EA Alabsi, ... BMC Health Services Research 18, 1-11, 2018 | 23 | 2018 |
Economic costs of obesity: a systematic review MA Nagi, H Ahmed, MAA Rezq, S Sangroongruangsri, U Chaikledkaew, ... International Journal of Obesity 48 (1), 33-43, 2024 | 22 | 2024 |
Barriers and facilitators of childhood COVID-19 vaccination among parents: A systematic review YH Khan, M Rasheed, TH Mallhi, M Salman, AI Alzarea, AS Alanazi, ... Frontiers in Pediatrics 10, 950406, 2022 | 22 | 2022 |
Meta-analysis of clinical trials comparing cefazolin to cefuroxime, ceftriaxone, and cefamandole for surgical site infection prevention NJ Ahmed, A Haseeb, A Alamer, ZS Almalki, AK Alahmari, AH Khan Antibiotics 11 (11), 1543, 2022 | 22 | 2022 |
Access to orphan drugs in the Middle East: Challenge and perspective ZS Almalki, AK Alahmari, JJ Guo, CML Kelton Intractable & Rare Diseases Research 1 (4), 139-143, 2012 | 20 | 2012 |
Comparing the impact of Hydroxychloroquine based regimens and standard treatment on COVID-19 patient outcomes: A retrospective cohort study SH Almazrou, ZS Almalki, AS Alanazi, AM Alqahtani, SM Alghamd Saudi Pharmaceutical Journal 28 (12), 1877-1882, 2020 | 18 | 2020 |
Off‐label use of oral fluoroquinolone antibiotics in outpatient settings in the United States, 2006 to 2012 ZS Almalki, AK Alahmari, JJ Guo, TM Cavanaugh Pharmacoepidemiology and drug safety 25 (9), 1042-1051, 2016 | 18 | 2016 |